Healthcare Roundup – New York City likely to stay in lockdown into June, Novavax up 26% on COVID-19 vaccine funding Life Science
Healthcare Roundup – AbbVie finalizes Allergan takeover, FDA OKs emergency use of COVID-19 test with saliva specimens Life Science
Healthcare Roundup – White House not on board with CDC reopening guidelines, Gilead confirms remdesivir approval in Japan for severe COVID-19 Life Science
Healthcare Roundup – White House coronavirus task force to ‘continue indefinitely’, Sinovac COVID-19 vaccine shows positive effect Life Science
Healthcare Roundup – FDA OKs emergency use of PerkinElmer COVID-19 blood test, Athersys up 3% premarket Life Science
Healthcare Roundup – Vir and Alnylam identify inhalable drug candidate for COVID-19, AmerisourceBergen eyes Walgreens’ drug distribution operation Life Science
Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells Life Science
Ascentage Pharma’s Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia Life Science
Healthcare Roundup – FDA OKs subcutaneous version of J&J’s Darzalex, European advisory group backs expanded label of Gilead’s Harvoni Life Science
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 Life Science
Bayer and OrigiMed reached a partnership to develop a next generation sequencing (NGS) based companion diagnostic-in vitro diagnostic (CDx-IVD) product in China for Larotrectinib, for NTRK gene fusion detection Life Science
Healthcare Roundup – AstraZeneca teams up with Oxford U. on COVID-19 vaccine, Molina to buy Magellan Life Science
Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula Life Science
